Combining forces, gathering strength in numbers and unifying resources are prevailing approaches to fend off opponents—but for healthcare and life sciences organizations, combining assets and resources is becoming standard operating procedure.
The pursuit of joint ventures, partnerships, strategic alliances and other collaborations has proven to be a blessing and a curse in health sectors, as risk and cost-sharing benefits in integrated clinical care or academic research contributions for pharma R&D offer improved time-to-value promises. Opportunities to extend reach into new markets or further into the patient care continuum through partnerships further elevate excitement. Often high enthusiasm to pounce on opportunities that aim to enhance customer experiences or R&D possibilities outshines addressing considerations and details carefully, turning market potential and synergistic promises into painful losses, and expensive corporate journeys. Key areas of spend are emerging:
Why partner now?
